✦ LIBER ✦

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

✍ Scribed by Ahn, J; Moore, S C; Albanes, D; Huang, W-Y; Leitzmann, M F; Hayes, R B

Book ID: 110000099
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 96 KB
Volume: 101
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diabetes mellitus and prostate cancer ri

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

✍ Michael F. Leitzmann; Jiyoung Ahn; Demetrius Albanes; Ann W. Hsing; Arthur Schat 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 246 KB

Repeat prostate biopsy in the Prostate,

Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial

✍ Paul F. Pinsky; E. David Crawford; Barnett S. Kramer; Gerald L. Andriole; Edward 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female

IGF-1 and IGFBP-3: Risk of prostate canc

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

✍ Jocelyn M. Weiss; Wen-Yi Huang; Sabina Rinaldi; Thomas R. Fears; Nilanjan Chatte 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 1 views

## Abstract IGF‐1 and IGFBP‐3 may influence risk of prostate cancer through their roles in cellular growth, metabolism and apoptosis, however, epidemiologic results have been inconsistent. The role of obesity in prostate cancer risk is not clearly understood, but hyperinsulinemia‐related increases

A national cancer institute sponsored sc

A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

✍ Barnett S. Kramer; John Gohagan; Philip C. Prorok; Charles Smart 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Background. Ovarian cancer is the fifth most common cause of cancer-related death in American women. The median age at diagnosis is about 62 years; incidence rises rapidly after age 60. Pelvic examination has been the primary method for detection of ovarian carcinoma. It is insensitive for the detec

Dietary carbohydrate, glycemic index, gl

Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort

✍ James M. Shikany; Andrew P. Flood; Cari M. Kitahara; Ann W. Hsing; Tamra E. Meye 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 217 KB